Quality of life aspects of a low protein diet using GMP in patients with phenylketonuria
Authors:
Open Access
- 22 September 2022
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (9)
Abstract
Objective: To assess some quality of life (QOL) aspects of a low protein diet, using glycomacropeptide (GMP) as a protein substitute in patients with phenylketonuria (PKU). Methods: This was a multicentre, prospective observational cohort, study. Metabolic control, nutritional parameters, and dietary adherence were assessed in patients with PKU before (T0), and six months after (T6) starting a low protein diet using GMP. Selected items from the PKU-QOL questionnaire were used to assess patients’ acceptance of their modified diet. Results: 18 patients from three Italian Centres, completed the study. With the exception of LDL-cholesterol and vitamin 25OH-D concentrations, there were no differences between T0 and T6 in metabolic or nutritional parameters. Data suggested that patients have a good acceptance of protein substitutes containing GMP, probably because of their improved palatability. Conclusions: According to our patients’ responses to items related to dietary regimen, GMP based protein substitutes do not appear to significantly affect QOL.Keywords
This publication has 18 references indexed in Scilit:
- Genetics of Phenylketonuria: Then and NowHuman Mutation, 2016
- Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countriesOrphanet Journal of Rare Diseases, 2015
- Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients’ and parents’ quality of life: the phenylketonuria – quality of life (PKU-QOL) questionnairesOrphanet Journal of Rare Diseases, 2015
- Sapropterin dihydrochloride for phenylketonuriaCochrane Database of Systematic Reviews, 2015
- Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide DietPLOS ONE, 2012
- PhenylketonuriaThe Lancet, 2010
- Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acidsThe American Journal of Clinical Nutrition, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKUMolecular Genetics and Metabolism, 2007
- Whey Protein Isolate and Glyco‐macropeptide Recovery from Whey Using Ion Exchange ChromatographyJournal of Food Science, 2003